-
Ab170472-10mgAbituzumab (anti-ITGAV) is a recombinant monoclonal antibody to ITGAV. Abituzumab effectively reduces the phosphorylation of FAK, Akt and ERK. Abituzumab can be used in cancer research, particularly in prostate cancer.Purity>:95%
-
Ab170472-1mgAbituzumab (anti-ITGAV) is a recombinant monoclonal antibody to ITGAV. Abituzumab effectively reduces the phosphorylation of FAK, Akt and ERK. Abituzumab can be used in cancer research, particularly in prostate cancer.Purity>:95%
-
Ab170472-5mgAbituzumab (anti-ITGAV) is a recombinant monoclonal antibody to ITGAV. Abituzumab effectively reduces the phosphorylation of FAK, Akt and ERK. Abituzumab can be used in cancer research, particularly in prostate cancer.Purity>:95%
-
-
-
A572873-100mlFormat:1-ComponentEnzyme:Horseradish peroxidase.
-
A342204-1mgAc-Arg-Leu-Arg-MCA is a substrate for 20S Proteasome.
-
A342204-5mgAc-Arg-Leu-Arg-MCA is a substrate for 20S Proteasome.
-
A397958-10mgac-BSA (10 mg/ml).
-
A397958-50mgac-BSA (10 mg/ml).
-
A378562-100mgAc-YEVD-AMCis a fluorogenic substrate for caspase-1 that is a cysteine protease activator of inflammatory processes which may be detected using a varieApplication:N-Acetyl-Asp-Glu-Val-Asp-7-amido-4-methylcoumarin has been used as a substrate for
-
A378562-10mgAc-YEVD-AMCis a fluorogenic substrate for caspase-1 that is a cysteine protease activator of inflammatory processes which may be detected using a varieApplication:N-Acetyl-Asp-Glu-Val-Asp-7-amido-4-methylcoumarin has been used as a substrate for